{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/83027-0304#drug","name":"Viri Sode","alternateName":"Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"83027-0304"},{"@type":"PropertyValue","propertyID":"UNII","value":"7COI029E6K|22G38P19RL|74J6DNH49U|AU5C98U4BB|6TU4EY6UNW|CYK5P89K8X|PS2DCE2WVF|U751HEX436|G54MT8V18G|77H9EM77P7|QI56415283|2A26YW7PNX|9885M7D6JP"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"8fb280d9-b79f-4b44-a534-89ddda0c2778"}],"activeIngredient":"HUMAN HERPESVIRUS 5, HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE, RUBELLA VIRUS, HEPATITIS A VIRUS, HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN HERPESVIRUS 4, HUMAN HERPESVIRUS 3","administrationRoute":["ORAL"],"dosageForm":"SPRAY","manufacturer":{"@type":"Organization","name":"Nutritional Specialties, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN OTC DRUG","sameAs":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fb280d9-b79f-4b44-a534-89ddda0c2778","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83027-0304"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T12:49:30.498Z"}}